Thu, 09/11/2017
Dorian Mc Gavern invited lecturer at FTN
Mainz. As Chief of the Viral Immunology and Intravital Imaging Section at the National Institute of Neurological Disorders and Stroke, Bethesda USA, Dr. Dorian McGavern investigates how the innate and adaptive immune systems participate in different neurological disorders such as meningitis, encephalitis, cerebral malaria, and TBI.In his lecture at Mainz FTN seminar, McGavern talks about […]...more
Thu, 09/11/2017
Elisabeth Schuh received SEED funding
Munich. SFB 128 researcher Elisabeth Schuh, MD, has been honoured by a young scientist’s studentship within the KKNMS SEED program. In her project „The role of the NLRP3 inflammasome in multiple sclerosis and experimental autoimmune encephalomyelitis“, Dr. Schuh analyses the influence of the NLRP3in MS. NLRP is a cytosolic protein complex in monocytes, macrophages and […]...more
Mon, 06/11/2017
Prof. Linington: Who needs a lymphocyte?
Mainz. SFB 128 researchers Prof. Jacky Trotter and Prof. Ari Waisman are proud to host Prof. Christopher Linington from the Institute of Infection, Immunity & Inflammation at the University of Glasgow for his lecture entitled “Who needs a lymphocyte? Non-immune-mediated demyelination in a novel model of progressive Multiple Sclerosis” Where?: Small Lecture Hall, Bldg 102, […]...more

Sun, 10/09/2017 | SFB researcher acquired Hertie foundation funding

Munich. SFB CRC 128 researcher Dr. Klaus Lehmann-Horn, Department of Neurology, has acquired 396.000€ of funding as part of the framework „MyLab“, which is sponsored by the Hertie foundation. The duration of the project „Antigen-driven affinity maturation of B lymphocytes in meningeal ectopic lymphoid tissue in a model of Multiple Sclerosis“ will be 5 years, starting on January 1st.